Gisela Schott

733 total citations
27 papers, 399 citations indexed

About

Gisela Schott is a scholar working on Economics and Econometrics, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gisela Schott has authored 27 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 10 papers in Pharmacology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gisela Schott's work include Pharmaceutical industry and healthcare (10 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Pharmaceutical Economics and Policy (6 papers). Gisela Schott is often cited by papers focused on Pharmaceutical industry and healthcare (10 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Pharmaceutical Economics and Policy (6 papers). Gisela Schott collaborates with scholars based in Germany, Sri Lanka and United Kingdom. Gisela Schott's co-authors include Wolfgang Ludwig, Klaus Lieb, Ursula Gundert‐Remy, Martin Schrappe, Jochen Harbott, Christian Sperling, Richard Ratei, F. Lampert, Leonid Karawajew and Norbert Graf and has published in prestigious journals such as PLoS Medicine, Nanotechnology and British Journal of Haematology.

In The Last Decade

Gisela Schott

26 papers receiving 379 citations

Peers

Gisela Schott
Eline van Overbeeke Belgium
Gabriella Bedarida United States
Chiara Whichello United States
John J. Ko United States
Robert Barrier United States
Tessel Rigter Netherlands
Peter Fox Australia
Cathy Anne Pinto United States
Peter J. Hulick United States
Deborah Casso United States
Eline van Overbeeke Belgium
Gisela Schott
Citations per year, relative to Gisela Schott Gisela Schott (= 1×) peers Eline van Overbeeke

Countries citing papers authored by Gisela Schott

Since Specialization
Citations

This map shows the geographic impact of Gisela Schott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gisela Schott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gisela Schott more than expected).

Fields of papers citing papers by Gisela Schott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gisela Schott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gisela Schott. The network helps show where Gisela Schott may publish in the future.

Co-authorship network of co-authors of Gisela Schott

This figure shows the co-authorship network connecting the top 25 collaborators of Gisela Schott. A scholar is included among the top collaborators of Gisela Schott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gisela Schott. Gisela Schott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Napierala, Hendrik, et al.. (2018). Management of financial conflicts of interests in clinical practice guidelines in Germany: results from the public database GuidelineWatch. BMC Medical Ethics. 19(1). 65–65. 13 indexed citations
3.
4.
Schott, Gisela, Klaus Lieb, J. König, et al.. (2015). Declaration and Handling of Conflicts of Interest in Guidelines. Deutsches Ärzteblatt international. 112(26). 445–51. 4 indexed citations
5.
Ludwig, Wolfgang & Gisela Schott. (2013). Neue Arzneimittel in der Onkologie: Merkmale klinischer Zulassungsstudien und Argumente für die rasche Durchführung unabhängiger klinischer Studien nach der Zulassung. Oncology Research and Treatment. 36(Suppl. 2). 17–22. 4 indexed citations
6.
Schott, Gisela, et al.. (2013). Does the Pharmaceutical Industry Influence Guidelines? Two Examples From Germany. Deutsches Ärzteblatt international. 110(35-36). 575–83. 15 indexed citations
7.
Schott, Gisela, et al.. (2011). Klinische Studien in der Onkologie – Defizite und Lösungsvorschläge. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 105(9). 657–664. 7 indexed citations
8.
Schott, Gisela, et al.. (2010). The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences. Deutsches Ärzteblatt international. 107(16). 279–85. 65 indexed citations
9.
Schott, Gisela, et al.. (2010). Publikationsbias in Abhängigkeit von der Art der Finanzierung bei klinischen Studien. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 104(4). 314–322. 6 indexed citations
10.
Ludwig, Wolfgang & Gisela Schott. (2010). Offene Fragen in der medikamentösen Tumortherapie mit neuen Wirkstoffen. Onkologie. 33(7). 6–10. 1 indexed citations
11.
Schott, Gisela, et al.. (2010). Finanzierung von Arzneimittelstudien durch pharmazeutische Unternehmen und die Folgen. Nanotechnology. 26(33). 335702–335702. 3 indexed citations
12.
Ludwig, Wolfgang, Martin Hildebrandt, & Gisela Schott. (2009). Interessenkonflikte und Arzneimittelstudien – Einfluss der pharmazeutischen Industrie und daraus resultierende Gefahren für die Integrität der medizinischen Wissenschaft. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 103(3). 149–154. 2 indexed citations
13.
Schott, Gisela, et al.. (2008). Therapieempfehlungen der Arzneimittelkommission der deutschen Ärzteschaft. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 102(4). 245–252. 6 indexed citations
14.
Schott, Gisela, et al.. (2007). Retrospective quantification of background incidence and stage distribution of breast cancer for the mammography screening pilot project in Wiesbaden, Germany. Journal of Cancer Research and Clinical Oncology. 134(1). 29–35. 1 indexed citations
15.
Schott, Gisela, Christian Sperling, Martin Schrappe, et al.. (1998). Immunophenotypic and clinical features of T‐cell receptor γδ+ T‐lineage acute lymphoblastic leukaemia. British Journal of Haematology. 101(4). 753–755. 19 indexed citations
16.
Ratei, Richard, Christian Sperling, Leonid Karawajew, et al.. (1998). Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. Annals of Hematology. 77(3). 107–114. 49 indexed citations
17.
Frydman, René, et al.. (1996). Maîtrise de la qualité sensorielle des produits déshydratés en relation avec la matière première et les conditions opératoires de la lyophilisation. HAL (Le Centre pour la Communication Scientifique Directe). 113(3). 87–90. 1 indexed citations
18.
Ludwig, W.-D., Andrea Reiter, Gisela Schott, Stefan Schwartz, & E. Thiel. (1994). [Immunophenotyping of acute lymphatic leukemia: diagnostic aspects and clinical relevance].. PubMed. 106(8). 231–2, 233.
19.
Pfeiffer, R. A., et al.. (1990). Robinow or “fetal face syndrome” in a male infant with ambiguous genitalia and androgen receptor deficiency. European Journal of Pediatrics. 149(9). 615–617. 6 indexed citations
20.
Schott, Gisela, et al.. (1982). [The prune-belly syndrome].. PubMed. 21(6). 322–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eline van Overbeeke Breakdown of academic impact, for papers by Gabriella Bedarida Breakdown of academic impact, for papers by Chiara Whichello Breakdown of academic impact, for papers by John J. Ko Breakdown of academic impact, for papers by Robert Barrier Breakdown of academic impact, for papers by Tessel Rigter Breakdown of academic impact, for papers by Peter Fox Breakdown of academic impact, for papers by Cathy Anne Pinto Breakdown of academic impact, for papers by Peter J. Hulick Breakdown of academic impact, for papers by Deborah Casso
Rankless by CCL
2026